Merck & Co., Inc. Revenue, Net (Deprecated 2018-01-31)
Merck & Co., Inc. (MRK) reported Revenue, Net (Deprecated 2018-01-31) of $11.58 billion for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-09.
Discontinued › Income Statement
us-gaap:SalesRevenueNet · last filed 2011-05-09
- Merck & Co., Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2011-03-31 was $11.58B, a 1.38% increase year-over-year.
- Merck & Co., Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2010-03-31 was $11.42B.
- Merck & Co., Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2009-09-30 was $4.50B, a 1.68% decline year-over-year.
- Merck & Co., Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2009-06-30 was $4.65B, a 5.57% decline year-over-year.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2011-03-31 | $11.58B 10-Q · filed 2011-05-09 | ||
| 2010-03-31 | $11.42B 10-Q · filed 2011-05-09 | ||
| 2009-09-30 | $4.50B 10-Q · filed 2009-10-29 | $9.15B derived: sum of 2 quarters · filed 2009-10-29 | $13.54B 10-Q · filed 2009-10-29 |
| 2009-06-30 | $4.65B 10-Q · filed 2009-07-24 | $9.04B 10-Q · filed 2009-07-24 | |
| 2008-09-30 | $4.58B 10-Q · filed 2009-10-29 | $9.50B derived: sum of 2 quarters · filed 2009-10-29 | $14.15B 10-Q · filed 2009-10-29 |
| 2008-06-30 | $4.92B 10-Q · filed 2009-07-24 | $9.58B 10-Q · filed 2009-07-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |